We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Covenant Logistics
CVLG
$872M
| $671K | ﹤0.01% |
27,232
-1,264
| -4% | -$29.4K |
|
2402
Xometry
XMTR
$5.34B
| $670K | ﹤0.01% |
58,002
+3,690
| +7% | +$58K |
|
2403
First Watch Restaurant Group
FWRG
$766M
| $669K | ﹤0.01% |
38,106
+7,631
| +25% | +$159K |
|
2404
EyePoint Inc
EYPT
$1.2B
| $668K | ﹤0.01% |
76,833
+18,897
| +33% | +$264K |
|
|
ITOS
2405
DELISTED
iTeos Therapeutics
ITOS
| $666K | ﹤0.01% |
44,861
+3,513
| +8% | +$50.3K |
|
2406
CNB Financial Corp
CCNE
$1.03B
| $663K | ﹤0.01% |
32,491
+180
| +0.6% | +$3.5K |
|
2407
Adtran
ADTN
$616M
| $660K | ﹤0.01% |
125,464
-110,811
| -47% | -$565K |
|
|
YMAB
2408
DELISTED
Y-mAbs Therapeutics
YMAB
| $657K | ﹤0.01% |
54,368
-856
| -2% | -$11.6K |
|
|
AIOT
2409
PowerFleet Inc
AIOT
$592M
| $656K | ﹤0.01% |
+143,551
| New | +$681K |
|
2410
Oric Pharmaceuticals
ORIC
$1.4B
| $655K | ﹤0.01% |
92,702
+32,402
| +54% | +$290K |
|
|
SEMR
2411
DELISTED
Semrush
SEMR
| $655K | ﹤0.01% |
48,912
+11,202
| +30% | +$155K |
|
2412
SmartRent
SMRT
$272M
| $654K | ﹤0.01% |
273,810
+7,597
| +3% | +$18.6K |
|
2413
Manitowoc
MTW
$675M
| $654K | ﹤0.01% |
56,757
+331
| +0.6% | +$4.09K |
|
2414
PLDT
PHI
$4.33B
| $654K | ﹤0.01% |
26,636
-1,270
| -5% | -$30.7K |
|
2415
Theravance Biopharma
TBPH
$877M
| $654K | ﹤0.01% |
77,084
-15,095
| -16% | -$136K |
|
2416
Stoke Therapeutics
STOK
$2.11B
| $647K | ﹤0.01% |
47,860
+5,990
| +14% | +$80.9K |
|
2417
Southern Missouri Bancorp
SMBC
$850M
| $646K | ﹤0.01% |
14,347
+263
| +2% | +$10.9K |
|
2418
Heron Therapeutics
HRTX
$92.9M
| $646K | ﹤0.01% |
184,472
+44,230
| +32% | +$136K |
|
2419
Blend Labs
BLND
$386M
| $645K | ﹤0.01% |
273,423
+267,307
| +4,371% | +$708K |
|
2420
Editas Medicine
EDIT
$442M
| $644K | ﹤0.01% |
137,986
+3,862
| +3% | +$21.8K |
|
2421
Medifast
MED
$141M
| $644K | ﹤0.01% |
29,504
-14,646
| -33% | -$390K |
|
2422
Northeast Bank
NBN
$1.14B
| $642K | ﹤0.01% |
10,554
-236
| -2% | -$13K |
|
2423
Arrow Financial
AROW
$652M
| $642K | ﹤0.01% |
24,650
+1,485
| +6% | +$35.6K |
|
2424
GSK
GSK
$106B
| $641K | ﹤0.01% |
16,662
+151
| +0.9% | +$6.35K |
|
2425
Olema Pharmaceuticals
OLMA
$1.05B
| $641K | ﹤0.01% |
59,261
+17,953
| +43% | +$195K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.